Donald Drakeman Ph.D

Donald Drakeman Ph.D General Information

Biography

Dr. Donald Drakeman serves as Venture Partner at Advent Life Sciences. He served as an Advisor at Immunome. He served as the Clinical and Scientific Advisor of Capella Bioscience. He was a Board Member at Gem Pharmaceuticals. He joined Advent in 2007 after 25 years as an entrepreneur and chief executive in the biotechnology industry, during which he co-founded Medarex Inc and Genmab A/S, both of which grew to be multi-billion-dollar companies. He has overseen the progression of numerous innovative medical products for cancer, infectious disease, and inflammation from research concepts to clinical trials. Several of them have now become FDA-approved products, including pioneering cancer treatments Yervoy and OpdivoTM. He takes Advisory, Board, and senior non-executive roles with our portfolio companies, including 4-antibody, Capella Biosciences, and Aleta Inc. He received an AB from Dartmouth College, a JD from Columbia University, and a Ph.D. in the Humanities from Princeton University, where he has served as a member of the Faculty. He is currently a Fellow in Health Management at the University of Cambridge.